Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 24,923 | Dovepress* | 20,043+ | 2,173 | 22,216 | |
| PubMed Central* | 4,880 | 1,357 | 6,237 | ||
| Totals | 24,923 | 3,530 | 28,453 | ||
|
*Since 15 October 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar